Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | ANNUAL REPORT | f20f2023_ysbiopharmaco.htm iXBRL | 20-F | 3356937 |
2 | DESCRIPTION OF SECURITIES | f20f2023ex2-1_ysbiopharmaco.htm | EX-2.1 | 44460 |
3 | LIST OF PRINCIPAL SUBSIDIARIES | f20f2023ex8-1_ysbiopharmaco.htm | EX-8.1 | 4751 |
4 | CERTIFICATION | f20f2023ex12-1_ysbiopharmaco.htm | EX-12.1 | 10622 |
5 | CERTIFICATION | f20f2023ex12-2_ysbiopharmaco.htm | EX-12.2 | 11194 |
6 | CERTIFICATION | f20f2023ex13-1_ysbiopharmaco.htm | EX-13.1 | 4382 |
7 | CERTIFICATION | f20f2023ex13-2_ysbiopharmaco.htm | EX-13.2 | 4405 |
8 | CONSENT OF WEI, WEI & CO., LLP., AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR | f20f2023ex15-1_ysbiopharmaco.htm | EX-15.1 | 2794 |
9 | GRAPHIC | image_001.jpg | GRAPHIC | 109945 |
10 | GRAPHIC | image_002.jpg | GRAPHIC | 111260 |
11 | GRAPHIC | image_003.jpg | GRAPHIC | 308227 |
12 | GRAPHIC | image_004.jpg | GRAPHIC | 69603 |
13 | GRAPHIC | image_005.jpg | GRAPHIC | 9480 |
14 | GRAPHIC | image_006.jpg | GRAPHIC | 57351 |
15 | GRAPHIC | image_007.jpg | GRAPHIC | 13673 |
16 | GRAPHIC | image_008.jpg | GRAPHIC | 48721 |
17 | GRAPHIC | image_009.jpg | GRAPHIC | 25984 |
18 | GRAPHIC | image_010.jpg | GRAPHIC | 22560 |
19 | GRAPHIC | image_011.jpg | GRAPHIC | 96361 |
20 | GRAPHIC | image_012.jpg | GRAPHIC | 52627 |
21 | GRAPHIC | image_013.jpg | GRAPHIC | 66050 |
22 | GRAPHIC | image_014.jpg | GRAPHIC | 43805 |
23 | GRAPHIC | image_015.jpg | GRAPHIC | 60970 |
24 | GRAPHIC | image_016.jpg | GRAPHIC | 69879 |
25 | GRAPHIC | image_017.jpg | GRAPHIC | 158120 |
26 | GRAPHIC | image_018.jpg | GRAPHIC | 66277 |
27 | GRAPHIC | image_019.jpg | GRAPHIC | 61685 |
28 | GRAPHIC | image_020.jpg | GRAPHIC | 50739 |
29 | GRAPHIC | image_021.jpg | GRAPHIC | 28143 |
30 | GRAPHIC | image_022.jpg | GRAPHIC | 24687 |
31 | GRAPHIC | image_023.jpg | GRAPHIC | 121038 |
32 | GRAPHIC | image_024.jpg | GRAPHIC | 25023 |
33 | GRAPHIC | image_025.jpg | GRAPHIC | 50079 |
34 | GRAPHIC | image_026.jpg | GRAPHIC | 35763 |
35 | GRAPHIC | image_027.jpg | GRAPHIC | 80700 |
36 | GRAPHIC | image_028.jpg | GRAPHIC | 149741 |
37 | GRAPHIC | image_029.jpg | GRAPHIC | 22601 |
38 | GRAPHIC | image_030.jpg | GRAPHIC | 78854 |
39 | GRAPHIC | image_031.jpg | GRAPHIC | 134184 |
40 | GRAPHIC | image_032.jpg | GRAPHIC | 99773 |
41 | GRAPHIC | image_033.jpg | GRAPHIC | 28857 |
42 | GRAPHIC | image_034.jpg | GRAPHIC | 67312 |
43 | GRAPHIC | image_035.jpg | GRAPHIC | 12982 |
44 | GRAPHIC | image_036.jpg | GRAPHIC | 33379 |
45 | GRAPHIC | image_037.jpg | GRAPHIC | 30232 |
46 | GRAPHIC | image_038.jpg | GRAPHIC | 13584 |
47 | GRAPHIC | image_039.jpg | GRAPHIC | 18910 |
48 | GRAPHIC | image_040.jpg | GRAPHIC | 27991 |
49 | GRAPHIC | image_041.jpg | GRAPHIC | 15977 |
50 | GRAPHIC | image_042.jpg | GRAPHIC | 16437 |
51 | GRAPHIC | ex15-1_001.jpg | GRAPHIC | 38793 |
52 | GRAPHIC | ex15-1_002.jpg | GRAPHIC | 15751 |
Complete submission text file | 0001213900-23-060012.txt | 19950592 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
53 | XBRL SCHEMA FILE | ys-20230331.xsd | EX-101.SCH | 142509 |
54 | XBRL CALCULATION FILE | ys-20230331_cal.xml | EX-101.CAL | 52512 |
55 | XBRL DEFINITION FILE | ys-20230331_def.xml | EX-101.DEF | 517851 |
56 | XBRL LABEL FILE | ys-20230331_lab.xml | EX-101.LAB | 986707 |
57 | XBRL PRESENTATION FILE | ys-20230331_pre.xml | EX-101.PRE | 543713 |
160 | EXTRACTED XBRL INSTANCE DOCUMENT | f20f2023_ysbiopharmaco_htm.xml | XML | 1707678 |
IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-41598 | Film No.: 231113448
SIC: 2834 Pharmaceutical Preparations